ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,528Medicare Part D Prescriptions Filled, Including Refills

Rank: 194 out of 783

$649K Total Retail Price of All Prescriptions

Rank: 170 out of 783

396 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 396 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

27% of this provider’s 396 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 4,871 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 531 193 S3 1 2
OMEPRAZOLE 348 218 2 6
LISINOPRIL 323 172 3 4
LEVOTHYROXINE SODIUM 292 188 4 1
SIMVASTATIN 283 142 5 3
ATORVASTATIN CALCIUM 247 171 6 11
AMLODIPINE BESYLATE 198 123 7 5
FUROSEMIDE 196 117 8 7
ALENDRONATE SODIUM 194 162 9 25
METFORMIN HCL 174 97 10 8
HYDROCHLOROTHIAZIDE 162 52 11 12
ADVAIR DISKUS 158 99 12 50
GABAPENTIN 153 55 13 15
NEXIUM 134 40 14 28
ZOLPIDEM TARTRATE 117 40 15 23
METOPROLOL SUCCINATE 115 73 16 13
SERTRALINE HCL 114 46 17 22
METOPROLOL TARTRATE 111 61 18 9
TRAMADOL HCL 98 56 19 20
CITALOPRAM HBR 98 49 19 19
LOSARTAN POTASSIUM 97 57 21 18
POTASSIUM CHLORIDE 94 63 22 16
PRAVASTATIN SODIUM 93 55 23 14
PROAIR HFA 93 37 23 56
CLONIDINE HCL 91 77 25 60
ATENOLOL 90 56 26 17
KLOR-CON M20 89 55 27 48
VENTOLIN HFA 87 24 28 159
TRAZODONE HCL 86 54 29 39
FLUOXETINE HCL 78 41 30 45
SPIRIVA 76 43 31 59
PAROXETINE HCL 73 18 32 69
CYCLOBENZAPRINE HCL 72 18 R 33 63
CYMBALTA 70 41 34 35
WARFARIN SODIUM 69 27 35 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 44 36 33
CRESTOR 65 34 37 27
RANITIDINE HCL 65 17 37 44
METFORMIN HCL ER 64 26 39 64
LANTUS 63 32 40 38
ROPINIROLE HCL 62 23 41 74
IBUPROFEN 58 0 42 115
NAPROXEN 58 19 42 104
ALLOPURINOL 56 55 44 31
AMITRIPTYLINE HCL 56 36 R 44 77
PROMETHAZINE HCL 54 0 R 46 97
CLOPIDOGREL 53 32 47 29
PLAVIX 52 38 48 51
COMBIVENT 51 16 49 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.